Biological variation of serum neuron‐specific enolase and carbohydrate antigen 724 tumor markers
Authors:
- 19 September 2017
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (4) , e22327
Abstract
Background: The aim of our study was to assess two tumor markers, carbohydrate antigen 724 (CA724) and neuron‐specific enolase (NSE), in 20 healthy individuals. Then, we determined their average intra‐ and inter‐individual biological variations (CVI and CVG).Methods: Blood samples were taken at weekly intervals for five weeks from 20 healthy subjects through a detailed questionnaire and physical examination. These samples were stored at −80°C and analyzed in a single run in duplicate. We calculated the biological variations, the reference change value (RCV), and the index of individuality (II) for the two tumor markers.Results: The intra‐individual and inter‐individual biological variations were 50.3% and 103.4% for CA724, and 10.1% and 12.0% for NSE, respectively. The II values for CA724 and NSE were 0.48 and 0.85, respectively.Conclusion: We determined the biological variations and indices of individuality for CA724 and NSE among 20 healthy subjects. These results will improve clinical applications of the markers.Keywords
Funding Information
- National Key Technologies R&D Program of China (2012BAI37B01)
This publication has 17 references indexed in Scilit:
- National cancer incidence and mortality in China, 20122016
- Biological variations of seven tumor markersClinica Chimica Acta, 2015
- Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolaseClinical Biochemistry, 2013
- Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese populationMolecular Biology Reports, 2012
- Reference change values may need some improvement but are invaluable tools in laboratory medicineClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Collective opinion paper on findings of the 2010 convocation of experts on laboratory qualityClinical Chemistry and Laboratory Medicine (CCLM), 2011
- ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.2008
- Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian CancerGynecologic Oncology, 1999
- Generation and Application of Data on Biological Variation in Clinical ChemistryCritical Reviews in Clinical Laboratory Sciences, 1989
- Desirable Performance Standards for Clinical Chemistry Tests1983